Related Experiment Videos
T-cell responses in rheumatoid arthritis: systemic abnormalities-local disease
1Department of Medicine, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA.
Current Opinion in Rheumatology
|May 18, 1999
Summary
Rheumatoid arthritis (RA) involves systemic T-cell abnormalities, not just joint inflammation. Altered T-cell pools and loss of diversity contribute to RA pathogenesis, suggesting broader therapeutic targets.
Area of Science:
- Immunology
- Rheumatology
- Systemic Autoimmune Diseases
Background:
- Rheumatoid arthritis (RA) is a systemic autoimmune disease causing joint inflammation.
- Pathogenic models must address RA's multiorgan involvement.
- Existing models may overlook systemic T-cell dysregulation.
Purpose of the Study:
- To propose that primary abnormalities in RA reside in T-cell pool assembly and homeostasis.
- To investigate the distinct CD4 T-cell repertoire in RA patients.
- To explore the implications of altered T-cell turnover and diversity in RA.
Main Methods:
- Analysis of T-cell repertoire and homeostasis in rheumatoid arthritis patients.
- Characterization of CD4 T-cell populations, including CD4+CD28null cells.
- Assessment of T-cell functional profiles, such as interferon-gamma production and cytotoxicity.
Main Results:
- RA patients exhibit a distinct CD4 T-cell repertoire with a high frequency of disease-relevant cells.
- Altered T-cell turnover leads to reduced diversity, replaced by expanding T-cell clones.
- Large clonal T-cell populations (CD4+CD28null) overproduce interferon-gamma and exhibit cytotoxicity.
Conclusions:
- Primary RA abnormalities involve T-cell pool assembly and homeostasis.
- Systemic T-cell dysfunction, including loss of diversity and expansion of proinflammatory clones, is central to RA.
- Therapies targeting only synovial inflammation may be insufficient for curative intervention in RA.